Global Non-invasive Cancer Diagnostic Market Size & Outlook
Global non-invasive cancer diagnostic market, 2021-2033 (US$M)
Related Markets
Global non-invasive cancer diagnostic market highlights
- The global non-invasive cancer diagnostic market generated a revenue of USD 80,870.4 million in 2025 and is expected to reach USD 139,091.7 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 7.1% by 2033.
- In terms of segment, instruments accounted for a revenue of USD 55,367.5 million in 2025.
- Instruments is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 80,870.4 million |
| Market revenue in 2033 | USD 139,091.7 million |
| Growth rate | 7.1% (CAGR from 2026 to 2033) |
| Largest segment | Instruments |
| Fastest growing segment | Instruments |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Kits & Reagents |
Other key industry trends
- In terms of revenue, the North America accounted for 41.2% of the global non-invasive cancer diagnostic market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 8,177.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-Invasive Cancer Diagnostic Market Scope
Non-Invasive Cancer Diagnostic Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fonar Corp. | View profile | 501-1000 | Melville, New York, United States, North America | http://www.fonar.com/ |
| GE Healthcare | View profile | - | - | - |
| Canon Medical Systems Corp. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Guardant Health Inc | View profile | 1779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | https://www.guardanthealth.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Global non-invasive cancer diagnostic market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive cancer diagnostic market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 68.46% in 2025. Horizon Databook has segmented the Global non-invasive cancer diagnostic market based on instruments, consumables, kits & reagents covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Non-Invasive Cancer Diagnostic Product Outlook (Revenue, USD Million, 2021-2033)
- Instruments
- Pathology-based Instruments
- Polymerase Chain Reaction (PCR) Instruments
- Next-generation Sequencing (NGS) Instruments
- Microarrays
- Imaging Instruments
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Mammography
- Others (Ultrasound, etc.)
- Pathology-based Instruments
- Consumables
- Kits & Reagents
- Instruments
- Global Non-Invasive Cancer Diagnostic Technology Outlook (Revenue, USD Million, 2021-2033)
- Imaging
- Liquid Biopsy
- Immunoassay
- Global Non-Invasive Cancer Diagnostic Indication Outlook (Revenue, USD Million, 2021-2033)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Cervical Cancer
- Skin Cancer
- Others (Thyroid Cancer, etc.)
- Global Non-Invasive Cancer Diagnostic End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Diagnostic Laboratories
- Others (Academic & Research Institutes, etc.)
Reasons to subscribe to Global non-invasive cancer diagnostic market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global non-invasive cancer diagnostic market databook
-
Our clientele includes a mix of non-invasive cancer diagnostic market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global non-invasive cancer diagnostic market , including forecasts for subscribers. This global databook contains high-level insights into Global non-invasive cancer diagnostic market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global non-invasive cancer diagnostic market size, by regions, 2021-2033 (US$M)
Top 10 countries: Non-invasive cancer diagnostic market size, 2025 (US$M)
Global non-invasive cancer diagnostic market share, by product, 2025 & 2033 (%, US$M)
Non-invasive cancer diagnostic market: Opportunity assessment by country
Global non-invasive cancer diagnostic market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
